In Thursday’s trading session on the BSE, shares of Sun Pharmaceutical Industries declined by 5%, reaching the day’s low of Rs 1,467. This drop occurred despite the company reporting a 34% year-on-year (YoY) increase in its Q4 profit to Rs 2,654.6 crore, with revenue rising by 10.1% YoY to Rs. 11,813 crore in Q4FY24.
Rise of new cities: Meet the new Gurgaons of India that are growing quietly but steadily
The Union government has outlined strategies to tackle rural unemployment and boost job growth in non-metro cities. The rise of satellite cities like Sri City,